Thi K. Le

Marseille, 13273, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773.

Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773.

Journal: Cancers

Published: February 28, 2026

Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.

Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.

Journal: Oncogene

Published: October 29, 2025

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 12, 2025

HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies.

HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 05, 2025

Author Correction: Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs.

Author Correction: Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs.

Journal: Communications biology

Published: July 10, 2025

Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.

Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.

Journal: Cell death & disease

Published: June 02, 2025

Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments.

Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments.

Journal: Cancers

Published: August 28, 2023

Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs.

Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs.

Journal: Communications biology

Published: August 22, 2023

ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines.

ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines.

Journal: Pharmaceutics

Published: June 07, 2023

Creating overview and summary figures.

Creating overview and summary figures.

Journal: Trends in biochemical sciences

Published: September 28, 2022

HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA.

HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA.

Journal: Cancers

Published: July 20, 2022

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 03, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026